FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC

Although targeted therapy has improved the survival rates in the last decade, non-small-cell lung cancer (NSCLC) is still the most common cause of cancer-related death. The challenge of identifying new targets for further effective therapies still remains. The FAMily with sequence similarity 83 (FAM...

Full description

Bibliographic Details
Main Authors: Sarah Richtmann, Dennis Wilkens, Arne Warth, Felix Lasitschka, Hauke Winter, Petros Christopoulos, Felix J. F. Herth, Thomas Muley, Michael Meister, Marc A. Schneider
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Cancers
Subjects:
NSCLC
FAM83A
FAM83B
biomarker
EGFR-TKI
Online Access:https://www.mdpi.com/2072-6694/11/5/652

Internet

https://www.mdpi.com/2072-6694/11/5/652

Similar Items